Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Clinical trial NCT04326374 · UNKNOWN

Trial details

NCT number: NCT04326374
Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency Endocrine System Diseases Hormones Pituitary Diseases Pituitary Disease, Anterior

Start date: 2019-12-30
Primary completion: 2022-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.